Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684775 · ClinicalTrials.gov registry record · Phase 2
Employment-Based Depot Naltrexone Clinical Trial II
A Phase 2 study of Opiate Dependence, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT00684775: Completed Phase 2 study of Opiate Dependence, sponsored by Johns Hopkins University.
NCT00684775 is a Phase 2 study of Opiate Dependence that has completed, run by Johns Hopkins University. The registered enrollment target is 38 participants, below the 605-participant average among 15 other Opiate Dependence trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00684775, a Phase 2 study of Opiate Dependence, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether employment-based naltrexone treatment proves effective in promoting depot naltrexone adherence and drug abstinence.
Primary Outcome
The percentage of depot naltrexone doses that participants received
Conditions Studied
Interventions
- COMBINATION_PRODUCT Work Plus Naltrexone Contingency
Study Locations (1)
Maryland
- The Center for Learning and Health - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-04-30 |
| Phase | Phase 2 |
What the finished NCT00684775 record still lists
NCT00684775 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 605-participant average among 15 other Opiate Dependence trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Opiate Dependence appearing as the primary indexed condition, and to 1 intervention - of which Work Plus Naltrexone Contingency is the first listed.
NCT00684775 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00684775 about?
NCT00684775 is a clinical study titled "Employment-Based Depot Naltrexone Clinical Trial II". The purpose of this study is to determine whether employment-based naltrexone treatment proves effective in promoting depot naltrexone adherence and drug abstinence.
What is the current status of trial NCT00684775?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2008-05. Estimated completion is 2010-04-30.
What conditions does trial NCT00684775 study?
This clinical trial studies the following conditions: Opiate Dependence.
What interventions are being tested in trial NCT00684775?
The interventions under investigation include: Work Plus Naltrexone Contingency (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00684775?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00684775 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00684775's enrollment target sits among peer trials
38 11th of 15 higher than 4 of 15 other Opiate Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opiate Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants
COMPLETED · Phase 2
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
-
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
COMPLETED · NA
-
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia